Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.51
+0.06 (1.10%)
Aug 8, 2025, 4:00 PM - Market closed

SpringWorks Therapeutics Revenue

Serina Therapeutics had revenue of $51.00K in the twelve months ending March 31, 2025, down -98.37% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.

Revenue (ttm)
$51.00K
Revenue Growth
-98.37%
P/S Ratio
1,076.87
Revenue / Employee
$3,923
Employees
13
Market Cap
54.92M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M2.56M433.05%
Dec 31, 2022591.50K-2.87M-82.93%
Dec 31, 20213.46M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.